| Entry |
|
|---|
| Name |
5-Fluorodeoxyuridine;
Floxuridine
|
|---|
| Formula |
C9H11FN2O5
|
|---|
| Exact mass |
246.0652
|
|---|
| Mol weight |
246.19
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00983 | Drug metabolism - other enzymes |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC09 Floxuridine
D04197 Floxuridine (USP/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antimetabolites
Floxuridine
D04197 Floxuridine (USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
D04197 Floxuridine
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D04197 Floxuridine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
TYMS
D04197 Floxuridine (USP/INN) <US>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1y C 25.6512 -17.9130
2 O2x O 24.5170 -17.1332
3 C1x C 25.2259 -19.2599
4 C1y C 23.3829 -17.9130
5 C1y C 23.8082 -19.2599
6 C1b C 22.1069 -17.4877
7 O1a O 23.0284 -20.3232
8 O1a O 21.1145 -18.4093
9 N4y N 26.9867 -17.4427
10 C8y C 27.9559 -18.4774
11 N4x N 29.3366 -18.1553
12 C8y C 29.7480 -16.7986
13 C8y C 28.7787 -15.7639
14 C8x C 27.3981 -16.0860
15 O5x O 27.5543 -19.8004
16 O5x O 31.1724 -16.4669
17 X F 29.1901 -14.4072
BOND 18
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 4 6 1 #Up
6 5 7 1 #Down
7 6 8 1
8 4 5 1
9 1 9 1 #Up
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 2
15 9 14 1
16 10 15 2
17 12 16 2
18 13 17 1
|
|---|
